FDA Inspection 1233723 — IQVIA RDS Shanghai
The FDA completed an inspection of IQVIA RDS Shanghai on Feb 2, 2024 in Shanghai. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Feb 2, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Shanghai (China)
Additional Details
Sponsor, Contract Research Organization